PRESS RELEASE: INDIANAPOLIS–(BUSINESS WIRE)–May 21, 2018– Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced it has closed on $1.8M in Series A financing to support the launch of its new microbiome platform technology. The funding re…Read More